Hyper Corporation

Hyper Corporation Enterprise Value

The Enterprise Value (EV) of Hyper Corporation (065650.KQ) as of Nov 4, 2026 is 26.88 B KRW. In the previous year, Enterprise Value (EV) was 25.01 B KRW — a change of 7.51% (higher).

Enterprise Value

26.88 BKRW

YoY

7.51%

Last updated:

Enterprise Value (EV) of Hyper Corporation is 2025 26.88 B KRW. Enterprise Value (EV) of Hyper Corporation was 2024 25.01 B KRW. It decreases by 7.51% higher compared to the previous year.

The Hyper Corporation Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2018
12.78 B KRW
Jan 1, 2019
16.94 B KRW
Jan 1, 2020
13.62 B KRW
Jan 1, 2021
17.79 B KRW
Jan 1, 2022
17.90 B KRW
Jan 1, 2023
26.88 B KRW
Jan 1, 2024
25.01 B KRW
Jan 1, 2025
26.88 B KRW
The Hyper Corporation Enterprise Value history
YEAREnterprise ValueYoY
26.88 BKRW+7.51%
25.01 BKRW-6.98%
26.88 BKRW+50.18%
17.90 BKRW+0.59%
17.79 BKRW+30.67%
13.62 BKRW-19.61%
16.94 BKRW+32.52%
12.78 BKRW+6.69%
11.98 BKRW-44.32%
21.52 BKRW-36.47%
33.87 BKRW+26.00%
26.88 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Hyper Corporation Stock analysis

What does Hyper Corporation do? Hyper Corporation Inc generates revenue through the Information Technology Business segment, which manufactures and sells mouses, monitors, televisions, routers, and game devices, while also operating Internet portals and specialized sites. The New Drug Business segment develops and sells non narcotic analgesics, Alzheimer's treatments, and Alzheimer's dementia diagnosis kits. The company's IT products are purchased by consumers and businesses seeking technology solutions, while the pharmaceutical products target healthcare providers and patients requiring pain management and cognitive health support. The Information Technology Business segment benefits from the sale of hardware devices and digital content services, with Internet portals and specialized sites driving user engagement and advertising revenue. The New Drug Business segment focuses on medical solutions for chronic conditions, serving both institutional and individual markets through direct sales channels. Both segments operate under the same corporate structure, leveraging the company's existing infrastructure for product development and distribution. Hyper Corporation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hyper Corporation stock

Enterprise Value (EV) of Hyper Corporation is 26.88 B KRW in 2025.

Enterprise Value (EV) of Hyper Corporation changed from 25.01 B KRW to 26.88 B KRW, representing a 7.51% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Hyper Corporation since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s KRW, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' KRW varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Hyper Corporation with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Hyper Corporation

All Key Metrics — Hyper Corporation